Does Metformin therapy impact CVD in T2D? It’s complicated
Metformin’s value as a glucose-lowering agent has been established for decades, but does it hold similar promise for reducing rates of
Keeping your diabetes kit safe and in one place.
Metformin’s value as a glucose-lowering agent has been established for decades, but does it hold similar promise for reducing rates of
Researchers at the University of Liverpool have found that the weight loss drug, Tirzepatide is associated with significantly reduced risk of
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for
Medtronic has announced plans to submit its MiniMed 780G for an expanded indication from the FDA for Type 2 diabetes in
Trial data has shown that the old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy
An upcoming document by a Lancet Commission of 56 of the world’s leading obesity experts will entirely reframe obesity as a